Serial Number | 97504271 |
Word Mark | PCC INSIDE |
Filing Date | Thursday, July 14, 2022 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Monday, February 26, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, May 30, 2023 |
Goods and Services | Research and development in the fields of imaging agents for medical diagnostic imaging, small molecule chemicals used as therapeutic agents and for the detection of antigens in cell and tissue analysis for in vitro diagnostic use |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, August 4, 2022 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Regeneron Pharmaceuticals, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Tarrytown, NY 10591 |
Party Name | Regeneron Pharmaceuticals, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Tarrytown, NY 10591 |
Event Date | Event Description |
Monday, February 26, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
Monday, February 26, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
Tuesday, July 25, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, May 30, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, May 30, 2023 | PUBLISHED FOR OPPOSITION |
Wednesday, May 10, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Sunday, April 23, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Monday, March 6, 2023 | ASSIGNED TO EXAMINER |
Thursday, August 4, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Monday, July 18, 2022 | NEW APPLICATION ENTERED |